Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 1.490
-0.010 (-0.67%)
Nov 4, 2025, 3:03 PM EST
Medicenna Therapeutics Employees
Medicenna Therapeutics had 18 employees as of March 31, 2025. The number of employees increased by 2 or 12.50% compared to the previous year.
Employees
18
Change (1Y)
2
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-727.56K CAD
Market Cap
125.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 18 | 2 | 12.50% |
| Mar 31, 2024 | 16 | 0 | - |
| Mar 31, 2023 | 16 | -2 | -11.11% |
| Mar 31, 2022 | 18 | 5 | 38.46% |
| Mar 31, 2021 | 13 | 6 | 85.71% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
Medicenna Therapeutics News
- 12 days ago - Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025 - GlobeNewsWire
- 15 days ago - Medicenna Therapeutics Announces Participation in Upcoming Conferences - GlobeNewsWire
- 5 weeks ago - Medicenna Announces Results of Annual Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know - Nasdaq
- 6 weeks ago - Medicenna Therapeutics Corp. (MDNA:CA) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow - Seeking Alpha
- 2 months ago - Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights - GlobeNewsWire
- 4 months ago - Medicenna Therapeutics GAAP EPS of -C$0.15 - Seeking Alpha